KCNJ5 and atrial fibrillation: Electrophysiological studies in a mouse model engineered to exhibit Kir3.4 autoimmunity have corroborated that Kir3.4 autoantibodies significantly reduce the atrial effective refractory period, consequently elevating the propensity for AF development [21].